Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology

QJM: An International Journal of Medicine

Volumn 101, Issue 4, 2008, Pages 317-323

  Wall, E ^a   Walker Bone, Karen ^a  

^a PRINCESS ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ETIDRONIC ACID; GLUCOCORTICOID; PREDNISOLONE; RISEDRONIC ACID; STEROID; VITAMIN D;

ADULT; BONE DENSITY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; RISK FACTOR; TEMPORAL ARTERITIS; UNITED KINGDOM;

EID: 41149136242     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcm126     Document Type: Review

References (32)

1. Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G. Corticosteroids and bone mass in asthma: Comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) 1986; 293:1463-6.
2. Reid IR, Grey AB. Corticosteroid osteoporosis. Baillieres Clin Rheumatol 1993; 7:573-87.
3. Van Staa TP. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif tissue int 2006; 79 129-37.
4. Sambrook PIN, Jones G. Corticosteroid osteoporosis. Brit J Rheumatol 1995; 34:8-12.
5. Bone and Tooth Society, National Osteoporosis Society, Royal College of Physicians. Glucocorticoid-induced osteoporosis: Guidelines for prevention and treatment. London, Royal College Physicians, 2002.
6. Royal College of Physicians. Osteoporosis: Clinical Guidelines for Prevention and Treatment. London, RCP, 1999.
7. National Osteoporosis Society. Guidelines on the prevention and management of glucocorticoid osteoporosis. Bath, National Osteoporosis Society, 1998.
8. American College of Rheumatology Ad Hoc Committee On Glucocorticoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 2001; 44:1496-503.
9. Peat ID, Healy S, Reid DM, Ralston SH. Steroid induced osteoporosis: An opportunity for prevention? Ann Rheum Dis 1995; 54:66-8.
10. Walsh L.J, Wong CA, Pringle M, Tattersfield A.E. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross-sectional study. BMJ 1996; 313:344-6.
11. van Staa T, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM 2000; 93 105-11.
12. Hart SR, Green B. Osteoporosis prophylaxis during corticosteroid treatment: Failure to prescribe. Postgrad Med J 2002; 78:572.
13. Chattopadhyay I, Showkathali AR, Jain AK. Osteoporosis prophylaxis during corticosteroid treatment. Postgrad Med J 2002; 78:572 [Letter].
14. Hodgkins B, Hull RG. Osteoporosis: A survey of consultant ophthalmologists. Br J Ophthalmol 1998; 82:203-4, [Letter].
15. Bell R, Carr A, Thompson P. Managing corticosteroid induced osteoporosis in medical outpatients. J R Coll Physicians (London) 1997; 31 158-61.
16. Buckley LM, Marquez M, Hudson JO, Downs RW, Vacek P, Small RE, et al Variations in physicians' judgements about corticosteroid induced osteoporosis by physician specialty. J Rheumatol 1998; 25 2195-202.
17. Smith MD, Cheah S, Taylor K, Ahern MJ. Prevention of corticosteroid induced osteoporosis by rheumatologists. J Rheumatol 2001; 27 1506-12.
18. Smith MD, Cheah SP, Taylor K, Ahern MJ. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital. J Rheumatol 2000; 28:566-70.
19. Cruse LM, Valeriano J, Vasey FB, Carter JC. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men. J Clin Rheumatol 2006; 12:221-5.
20. Feldstein AC, Elmer PJ, Nichols GA, Herson M. Practice patterns in patients at risk for glucorticoid-induced osteoporosis. Osteoporosis Int 2005; 16:2168-74.
21. Saag KG, Gehlbach SH, Curtis JR, Youket TE, Worley K, Lange JL. Trends in prevention of glucocorticoid-induced osteoporosis. J Rheumatol 2006; 33:1651-7.
22. Erb N, Duncan RC, Raza K, Rowe IF, Kitas GD, Situnayake RD, et al. A regional audit of the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases in the West Midlands. Rheumatology 2002; 41:1021-4.
23. Walker-Bone K, Wood A, Hull R, Ledingham JM, McCrae FC, Shaban R, et al. The prevention and treatment of glucocorticoid-induced osteroporosis in clinical practice. Clin Med 2004; 4:431-6.
24. Paskins Z, Potter T, Erb N, Obrenovic K, Rowe IF. West Midlands Rheumatology Services Training Committee. Audits of the prevention and treatment of corticosteroid-induced osteoporosis in outpatients with rheumatic diseases in the West Midlands. Clin Med 2006; 6 183-7.
25. van Staa T, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Mener Res 2000; 15:993-1000.
26. Pearce G, Ryan PFJ, Delmas PD, Tabensky DA, Seeman E. The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica. Br J Rheumatol 1998; 37:292-9.
27. Bayly JR, Hollands RD, Roirdan-Jones SE, Yemm SJ, Brough-Williams I, Thatcher M, et al. Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: A report of a pilot study. Curr Med Res Opin 2006; 22:131-7.
28. Eastell R. Management of corticosteroid-induced osteoporosis. J Intern Med 1995; 237:439-47.
29. Geralyi F, Loven B, Rodriguez JE. Do inhaled steroids increase the risk of osteoporosis. J Fam Pract 2007; 56:131-6.
30. Choy EH, Kingsley GH, Khoshaba B, Pipitone N, Scott DL. The Intramuscular Methylprednisolone Study Group. A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs. Ann Rheum Dis 2005; 64:1288-93.
31. Haugeberg G, Griffiths B, Sokoll KB, Emery P. Bone loss in patients treated with pulses of methylprednisolone is not negligible: A short term prospective observational study. Ann Rheum Dis 2004; 63 940-4.
32. Weitoft T, Larsson A, Saxne T, Rönnblom. Changes of cartilage and bone markers after intra-articular glucocoritcoid treatment with and without postinjeciton rest in patients with rheumatoid arthritis. Ann Rheum Dis 2005; 64:1750-3.